PrimaGen – Amsterdam Academic Ventures

Our portfolio

PrimaGen

PrimaGen Holding focuses on developing molecular diagnostic tests and investing in bio- and medtech startups. The company generates revenues through the licensing of their diagnostics technology. PrimaGen Holding’s portfolio includes investments in PulseCath and Akkolens International.

Industry: Diagnostics, Infectious Disease

Want to get in contact about PrimaGen?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Developing rapid human gut microbiota analysis.

Specializing in AI-powered audience intelligence, Sightcorp provides automated facial analysis and emotion recognition technology.

Improving orthopedic diagnostics with advanced joint loading and imaging technology.

GuanaRep

Repurposing hypertension drugs for treating rare neurological diseases.

Developing rapid human gut microbiota analysis.

Specializing in AI-powered audience intelligence, Sightcorp provides automated facial analysis and emotion recognition technology.

Improving orthopedic diagnostics with advanced joint loading and imaging technology.

GuanaRep

Repurposing hypertension drugs for treating rare neurological diseases.

Our portfolio

Want to get in contact about PrimaGen?

Marc Roelofs

Our portfolio

Holdings of our founding institutes

Contact